Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.
Saved in:
| Title: | Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy. |
|---|---|
| Authors: | Antolí A; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Rocamora-Blanch G; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Framil M; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Mas-Bosch V; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Navarro S; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Bermudez C; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Martinez-Yelamos S; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Dopico E; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Deparment of Microbiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Calatayud L; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Deparment of Microbiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain., Garcia-Muñoz N; Blood Bank Department - Banc de Sang i Teixits (BST), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Hernández-Benítez LH; Blood Bank Department - Banc de Sang i Teixits (BST), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Riera-Mestre A; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Bas J; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Masuet-Aumatell C; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Preventive Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Rigo-Bonnin R; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Morandeira F; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Solanich X; Department of Internal Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Adults Primary Immunodeficiency Unit (UFIPA), Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Apr 29; Vol. 13, pp. 895209. Date of Electronic Publication: 2022 Apr 29 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2022.895209 |
